Adeniyi Francis Fagbamigbe

InstitutionUniversity of Ibadan
AddressIbadan
Nigeria
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 7 Covid-19 publications, with a maximum of 2 publications in January 2021 and June 2021
    All Publications
    Bar chart showing 30 publications over 10 distinct years, with a maximum of 7 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Ayodele KP, Jimoh H, Fagbamigbe AF, Onakpoya OH. The dynamics of COVID-19 outbreak in Nigeria: A sub-national analysis. Sci Afr. 2021 Sep; 13:e00914. PMID: 34395958.
      Citations:    
    2. Adebowale AS, Fagbamigbe AF, Akinyemi JO, Obisesan KO, Awosanya EJ, Afolabi RF, Alarape SA, Obabiyi SO. Situation assessment and natural dynamics of COVID-19 pandemic in Nigeria, 31 May 2020. Sci Afr. 2021 Jul; 12:e00844. PMID: 34308003.
      Citations:    
    3. Badu K, Oyebola K, Zahouli JZB, Fagbamigbe AF, de Souza DK, Dukhi N, Amankwaa EF, Tolba MF, Sylverken AA, Mosi L, Mante PK, Matoke-Muhia D, Goonoo N. SARS-CoV-2 Viral Shedding and Transmission Dynamics: Implications of WHO COVID-19 Discharge Guidelines. Front Med (Lausanne). 2021; 8:648660. PMID: 34239886.
      Citations: 1     
    4. Wegbom AI, Edet CK, Raimi O, Fagbamigbe AF, Kiri VA. Self-Medication Practices and Associated Factors in the Prevention and/or Treatment of COVID-19 Virus: A Population-Based Survey in Nigeria. Front Public Health. 2021; 9:606801. PMID: 34150693.
      Citations: 4     Translation:Humans
    5. Mosi L, Sylverken AA, Oyebola K, Badu K, Dukhi N, Goonoo N, Mante PK, Zahouli J, Amankwaa EF, Tolba MF, Fagbamigbe AF, de Souza DK, Matoke-Muhia D. Correlating WHO COVID-19 interim guideline 2020.5 and testing capacity, accuracy, and logistical challenges in Africa. Pan Afr Med J. 2021; 39:89. PMID: 34466191.
      Citations:    Fields:    Translation:HumansPHPublic Health
    6. Adebowale AS, Fagbamigbe AF, Akinyemi JO, Obisesan OK, Awosanya EJ, Afolabi RF, Alarape SA, Obabiyi SO. The spread of COVID-19 outbreak in the first 120 days: a comparison between Nigeria and seven other countries. BMC Public Health. 2021 01 12; 21(1):129. PMID: 33435922.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    7. Olagunju A, Fowotade A, Olagunoye A, Ojo TO, Adefuye BO, Fagbamigbe AF, Adebiyi AO, Olagunju OI, Ladipo OT, Akinloye A, Adeagbo BA, Onayade A, Bolaji OO, Happi C, Rannard S, Owen A. Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Jan 04; 22(1):3. PMID: 33397457.
      Citations:    Fields:    Translation:HumansCTClinical Trials